The Sharon Roloff Osteosarcoma Fund

Sharon

My Story: In November 2012 at the age of 47, I was diagnosed with osteosarcoma in my right tibia. Osteosarcoma is an aggressive bone cancer. It usually occurs in children and young adults. There have been no new treatments in over 40 years.  

First-line treatment for osteosarcoma is to remove the affected bone. After three rounds of chemotherapy, I had Limb Salvage Surgery in February 2013. When my skin had healed enough, I was back on a highly toxic regiment of high-dose chemotherapy. A year after completing chemo, the cancer had metastasized to many of my bones. Since there are no new therapies for this type of cancer, we have tried radiation to reduce the tumor burden and pain. The cancer is now on just about every vertebrae and is compressing on my spinal cord. I’ve been blessed though because usually, osteosarcoma goes to the lungs, and after 5 1/2 years I’ve had bone only.

So I feel very lucky I’ve lived this long. The doctors were amazed that my disease stayed in my bones and did not reach my lung until recently. The cancer has spread to the pleural lining of my right lung. At this point, hospice has taken over but I’m still fighting.

Why MIB Agents: I have met so many who have helped me over the past 5 1/2 years, many of whom are still fighting, like me. There have also been far too many who have passed. My husband, I went to the first osteosarcoma conference in Coral Gables, put on by MIB Agents. We both learned so much and it was there that I met the best doctors and had all my questions answered. We also met Ann Graham, an osteosarcoma survivor, who founded MIB Agents to help kids and families who have osteosarcoma. Ann and I were both diagnosed as adults with this typically pediatric cancer. We have stayed in contact ever since.

MIB provides direct patient support, plans and executes the annual osteosarcoma conference and funds meaningful research. So it’s my honor to help raise funds towards this 501(c)(3) non-profit, with a fund they named in my honor, The Sharon Roloff Osteosarcoma Fund.

No items found.
No items found.
No items found.

Our Mission

MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.
Supporting Doctors, Researchers, and the Medical Community
FACTOR Osteosarcoma Conference

FACTOR brings together the leading researchers, clinicians, surgeons, together with patient families and OsteoWarriors to Make It Better for those battling this disease.

Annual OutSmarting Osteosarcoma Grant

Each year a grant of $100,000 is awarded to a project that will focus on moving research forward for osteosarcoma patients.

Osteosarcoma Resources for you to give to patients

Browse our extensive list of osteosarcoma resources from MIB Agents and our partner organizations.

OsteoBites Weekly Webinar

OsteoBites is a weekly webinar and podcast where we invite Osteosarcoma Experts and OsteoWarriors to share their research, hope, and innovation.

Supporting Kids and Young Adults with Osteosarcoma
Gamer Agents

Agent GAMERS game with their fellow OsteoWarriors and OsteoSiblings.

Ambassador Agents

Ambassador Agents are certified peer visitors who provide hope, understanding, and resources.

Warrior Mail

OsteoWarriors receive monthly letters of hope and cheer from MIB Agent Writers around the world.

Missions

When an OsteoWarrior transitions to hospice care, MIB Agents provides an experience or an item of comfort and entertainment.

HQ at FACTOR Osteosarcoma Conference

The OsteoWarriors HQ (headquarters) brings kids and young adults who have a connection to osteosarcoma together and It. Is. Awesome!

Vision

A world with less toxic, more effective treatments and a cure for osteosarcoma.

Values

We are devoted to creating and instilling hope with and for our inclusive and collaborative osteosarcoma community. We do this through mutual trust, transparency and compassion.